| Bioactivity | GSK951A is a THPP analogue. GSK951A inhibits mycolic acid biosynthesis. GSK951A combines potency in culture with in vivo activity and lack of cytotoxicity[1]. |
| Name | GSK951A |
| CAS | 1403602-33-4 |
| Formula | C24H23F3N4O3 |
| Molar Mass | 472.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cox JA, et al. THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria. Nat Microbiol. 2016;1:15006. |
GSK951A
CAS: 1403602-33-4 F: C24H23F3N4O3 W: 472.46
GSK951A is a THPP analogue. GSK951A inhibits mycolic acid biosynthesis. GSK951A combines potency in culture with in vivo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.